These indirect antitumor effects were observed by ACT of Th1 (28) as well as Th2 (29) CD4+ T cells, suggesting in a view of the Th2-skewing hypothesis of tumor escape (30) that CD4+ T cells have antitumor potential at both earlier as well as later stages of tumor growth. This evidence concerns the gene CD4 and neoplasm.